Back

Discussion - Biomarker guidance to start remote patient management in heart failure.

26 May 2019 (09:45 - 09:48)
Organised by:
Congress Presentation Part of: Late breaking trial II - Chronic heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2019

12 More presentations in this session

Presentation thumbnail
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial
Professor M. Schulz (Leipzig, DE)
Slides Video
Presentation thumbnail
Discussion - PHARM-CHF
Video
Presentation thumbnail
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure
Professor P. Rossignol (Monaco, MC)
Slides Video
Presentation thumbnail
Discussion - AMBER.
Video
Presentation thumbnail
Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial
Doctor A. Biolo (Porto Alegre, BR)
Slides Video

Access the full session

Session thumbnail
Late breaking trial II - Chronic heart failure

The Event

Event poster

Heart Failure 2019

26 May 2019 09:45 CET
You may be interested in
thumbnail
Congress Presentation
Can remote CIED monitoring improve clinical outcomes in heart failure?
4 April 2022
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Session
HFpEF: modern approaches to diagnosis and management
17 May 2025
thumbnail
Congress Presentation
Use of a remote telemonitoring platform significantly improves medication optimisation in heart failure patients
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources